LUND, SE / ACCESS Newswire / July 2, 2026 / Alligator Bioscience (STO:ATORX)First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or without intratumoral ...

For people at high risk of developing breast cancer, yearly mammograms may not be enough to detect tumors early.

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, ...

The red cells are genetically engineered macrophages designed to selectively recognize, engulf and destroy breast cancer cells (blue), demonstrating a promising new cell-based immunotherapy approach.

When Erika Wurth found a lump in her right breast just after her 50 th birthday, her first thought was she didn’t want to die ...

University of West Florida Assistant Professor of Public Health Dr. Karishma Chhabria Unrue has been awarded a nearly $825,000 grant through the Florida Cancer Innovation Fund to lead a statewide ...

The FDA has approved sacituzumab govitecan-hziy as first-line therapy for adults with unresectable locally advanced or ...

(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...

Regulatory labeling stratifies use by PD-L1 status: monotherapy for PD-L1–negative/checkpoint-ineligible disease and combination with pembrolizumab (or Qlex) for PD ...

(NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE ® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the ...

For 80 years Oak Ridge National Laboratory has produced isotopes that treat cancer and power deep space exploration.